REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 28 filers reported holding REGULUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | 0.0% | 11,200 | +4.7% | 0.00% | – |
| Q4 2021 | $3,000 | -57.1% | 10,700 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | -22.2% | 10,700 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -47.1% | 10,700 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | +13.3% | 10,700 | -4.5% | 0.00% | – |
| Q4 2020 | $15,000 | +150.0% | 11,200 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -25.0% | 11,200 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | +60.0% | 11,200 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -44.4% | 11,200 | +9.8% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 10,200 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -46.2% | 10,200 | +1.3% | 0.00% | – |
| Q2 2019 | $13,000 | +30.0% | 10,065 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | – | 10,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 5,555,555 | $1,656,000 | 0.43% |
| NEA Management Company, LLC | 14,451,147 | $4,306,000 | 0.12% |
| Sarissa Capital Management LP | 1,851,851 | $552,000 | 0.05% |
| Ikarian Capital, LLC | 1,289,130 | $384,000 | 0.05% |
| FEDERATED HERMES, INC. | 29,048,265 | $8,656,000 | 0.02% |
| WealthTrust Axiom LLC | 68,000 | $20,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $4,000 | 0.00% |
| GYL FINANCIAL SYNERGIES, LLC | 34,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,056 | $37,000 | 0.00% |
| McGuire Investment Group, LLC | 15,000 | $4,000 | 0.00% |